▶ 調査レポート

睡眠障害治療の世界市場 2020年

• 英文タイトル:Global Sleep Disorder Therapies Market 2020 by Company, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。睡眠障害治療の世界市場 2020年 / Global Sleep Disorder Therapies Market 2020 by Company, Regions, Type and Application, Forecast to 2025 / GIR201115137資料のイメージです。• レポートコード:GIR201115137
• 出版社/出版日:GlobalInfoResearch / 2020年10月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、107ページ
• 納品方法:Eメール
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本書では、睡眠障害治療の世界市場を調査対象にし、睡眠障害治療の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析(北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ)、種類別分析(不眠症、過眠、睡眠障害)、用途別分析(病院薬局、オンライン薬局、小売薬局)、市場予測(2021年~2025年)情報などを整理しました。
・市場概要
・企業情報:Sanofi、Vanda Pharmaceuticals、Fisher and Paykel Healthcare、Phillips Healthcare、Sleep Number、Nox Medical、Neurim Pharmaceuticals、Eight Sleep、Responsive Surface Technology、Eli Lilly、Merck
・企業別売上、市場シェア
・睡眠障害治療の地域別市場分析
・睡眠障害治療の北米市場規模2015-2020:アメリカ、カナダ、メキシコ
・睡眠障害治療のヨーロッパ市場規模2015-2020:ドイツ、イギリス、フランス、ロシアなど
・睡眠障害治療のアジア市場規模2015-2020:日本、中国、韓国、インド、東南アジアなど
・睡眠障害治療の南米市場規模2015-2020:ブラジル、アルゼンチンなど
・睡眠障害治療の中東・アフリカ市場規模2015-2020:サウジアラビア、トルコ、エジプト、南アフリカなど
・睡眠障害治療の種類別市場規模2015-2020:不眠症、過眠、睡眠障害
・睡眠障害治療の用途別市場規模2015-2020:病院薬局、オンライン薬局、小売薬局
・睡眠障害治療の世界市場予測2021-2025:地域別、種類別、用途別
・調査の結果・結論

Market Overview
The global Sleep Disorder Therapies market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Sleep Disorder Therapies market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Sleep Disorder Therapies market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Sleep Disorder Therapies market has been segmented into:
Insomnia
Excessive Sleep
Disturbed Sleep

By Application, Sleep Disorder Therapies has been segmented into:
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Sleep Disorder Therapies market presented in the report. This section sheds light on the sales growth of different regional and country-level Sleep Disorder Therapies markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Sleep Disorder Therapies market.

The report offers in-depth assessment of the growth and other aspects of the Sleep Disorder Therapies market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Sleep Disorder Therapies Market Share Analysis
Sleep Disorder Therapies competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Sleep Disorder Therapies sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Sleep Disorder Therapies sales, revenue and market share for each player covered in this report.

The major players covered in Sleep Disorder Therapies are:
Sanofi
Vanda Pharmaceuticals
Fisher and Paykel Healthcare
Phillips Healthcare
Sleep Number
Nox Medical
Neurim Pharmaceuticals
Eight Sleep
Responsive Surface Technology
Eli Lilly
Merck

レポート目次

1 Sleep Disorder Therapies Market Overview
1.1 Product Overview and Scope of Sleep Disorder Therapies
1.2 Classification of Sleep Disorder Therapies by Type
1.2.1 Global Sleep Disorder Therapies Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Sleep Disorder Therapies Revenue Market Share by Type in 2019
1.2.3 Insomnia
1.2.4 Excessive Sleep
1.2.5 Disturbed Sleep
1.3 Global Sleep Disorder Therapies Market by Application
1.3.1 Overview: Global Sleep Disorder Therapies Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Retail Pharmacies
1.4 Global Sleep Disorder Therapies Market by Regions
1.4.1 Global Sleep Disorder Therapies Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Sleep Disorder Therapies (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Sleep Disorder Therapies Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Sleep Disorder Therapies Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Sleep Disorder Therapies Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Sleep Disorder Therapies Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Sleep Disorder Therapies Status and Prospect (2015-2025)
2 Company Profiles
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Sanofi SWOT Analysis
2.1.4 Sanofi Product and Services
2.1.5 Sanofi Sleep Disorder Therapies Revenue, Gross Margin and Market Share (2018-2019)
2.2 Vanda Pharmaceuticals
2.2.1 Vanda Pharmaceuticals Details
2.2.2 Vanda Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Vanda Pharmaceuticals SWOT Analysis
2.2.4 Vanda Pharmaceuticals Product and Services
2.2.5 Vanda Pharmaceuticals Sleep Disorder Therapies Revenue, Gross Margin and Market Share (2018-2019)
2.3 Fisher and Paykel Healthcare
2.3.1 Fisher and Paykel Healthcare Details
2.3.2 Fisher and Paykel Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Fisher and Paykel Healthcare SWOT Analysis
2.3.4 Fisher and Paykel Healthcare Product and Services
2.3.5 Fisher and Paykel Healthcare Sleep Disorder Therapies Revenue, Gross Margin and Market Share (2018-2019)
2.4 Phillips Healthcare
2.4.1 Phillips Healthcare Details
2.4.2 Phillips Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Phillips Healthcare SWOT Analysis
2.4.4 Phillips Healthcare Product and Services
2.4.5 Phillips Healthcare Sleep Disorder Therapies Revenue, Gross Margin and Market Share (2018-2019)
2.5 Sleep Number
2.5.1 Sleep Number Details
2.5.2 Sleep Number Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Sleep Number SWOT Analysis
2.5.4 Sleep Number Product and Services
2.5.5 Sleep Number Sleep Disorder Therapies Revenue, Gross Margin and Market Share (2018-2019)
2.6 Nox Medical
2.6.1 Nox Medical Details
2.6.2 Nox Medical Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Nox Medical SWOT Analysis
2.6.4 Nox Medical Product and Services
2.6.5 Nox Medical Sleep Disorder Therapies Revenue, Gross Margin and Market Share (2018-2019)
2.7 Neurim Pharmaceuticals
2.7.1 Neurim Pharmaceuticals Details
2.7.2 Neurim Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Neurim Pharmaceuticals SWOT Analysis
2.7.4 Neurim Pharmaceuticals Product and Services
2.7.5 Neurim Pharmaceuticals Sleep Disorder Therapies Revenue, Gross Margin and Market Share (2018-2019)
2.8 Eight Sleep
2.8.1 Eight Sleep Details
2.8.2 Eight Sleep Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Eight Sleep SWOT Analysis
2.8.4 Eight Sleep Product and Services
2.8.5 Eight Sleep Sleep Disorder Therapies Revenue, Gross Margin and Market Share (2018-2019)
2.9 Responsive Surface Technology
2.9.1 Responsive Surface Technology Details
2.9.2 Responsive Surface Technology Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Responsive Surface Technology SWOT Analysis
2.9.4 Responsive Surface Technology Product and Services
2.9.5 Responsive Surface Technology Sleep Disorder Therapies Revenue, Gross Margin and Market Share (2018-2019)
2.10 Eli Lilly
2.10.1 Eli Lilly Details
2.10.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Eli Lilly SWOT Analysis
2.10.4 Eli Lilly Product and Services
2.10.5 Eli Lilly Sleep Disorder Therapies Revenue, Gross Margin and Market Share (2018-2019)
2.11 Merck
2.11.1 Merck Details
2.11.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Merck SWOT Analysis
2.11.4 Merck Product and Services
2.11.5 Merck Sleep Disorder Therapies Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Sleep Disorder Therapies Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Sleep Disorder Therapies Players Market Share
3.2.2 Top 10 Sleep Disorder Therapies Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Sleep Disorder Therapies Revenue and Market Share by Regions
4.2 North America Sleep Disorder Therapies Revenue and Growth Rate (2015-2020)
4.3 Europe Sleep Disorder Therapies Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Sleep Disorder Therapies Revenue and Growth Rate (2015-2020)
4.5 South America Sleep Disorder Therapies Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Sleep Disorder Therapies Revenue and Growth Rate (2015-2020)
5 North America Sleep Disorder Therapies Revenue by Countries
5.1 North America Sleep Disorder Therapies Revenue by Countries (2015-2020)
5.2 USA Sleep Disorder Therapies Revenue and Growth Rate (2015-2020)
5.3 Canada Sleep Disorder Therapies Revenue and Growth Rate (2015-2020)
5.4 Mexico Sleep Disorder Therapies Revenue and Growth Rate (2015-2020)
6 Europe Sleep Disorder Therapies Revenue by Countries
6.1 Europe Sleep Disorder Therapies Revenue by Countries (2015-2020)
6.2 Germany Sleep Disorder Therapies Revenue and Growth Rate (2015-2020)
6.3 UK Sleep Disorder Therapies Revenue and Growth Rate (2015-2020)
6.4 France Sleep Disorder Therapies Revenue and Growth Rate (2015-2020)
6.5 Russia Sleep Disorder Therapies Revenue and Growth Rate (2015-2020)
6.6 Italy Sleep Disorder Therapies Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Sleep Disorder Therapies Revenue by Countries
7.1 Asia-Pacific Sleep Disorder Therapies Revenue by Countries (2015-2020)
7.2 China Sleep Disorder Therapies Revenue and Growth Rate (2015-2020)
7.3 Japan Sleep Disorder Therapies Revenue and Growth Rate (2015-2020)
7.4 Korea Sleep Disorder Therapies Revenue and Growth Rate (2015-2020)
7.5 India Sleep Disorder Therapies Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Sleep Disorder Therapies Revenue and Growth Rate (2015-2020)
8 South America Sleep Disorder Therapies Revenue by Countries
8.1 South America Sleep Disorder Therapies Revenue by Countries (2015-2020)
8.2 Brazil Sleep Disorder Therapies Revenue and Growth Rate (2015-2020)
8.3 Argentina Sleep Disorder Therapies Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Sleep Disorder Therapies by Countries
9.1 Middle East & Africa Sleep Disorder Therapies Revenue by Countries (2015-2020)
9.2 Saudi Arabia Sleep Disorder Therapies Revenue and Growth Rate (2015-2020)
9.3 UAE Sleep Disorder Therapies Revenue and Growth Rate (2015-2020)
9.4 Egypt Sleep Disorder Therapies Revenue and Growth Rate (2015-2020)
9.5 South Africa Sleep Disorder Therapies Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Sleep Disorder Therapies Revenue and Market Share by Type (2015-2020)
10.2 Global Sleep Disorder Therapies Market Forecast by Type (2019-2024)
10.3 Insomnia Revenue Growth Rate (2015-2025)
10.4 Excessive Sleep Revenue Growth Rate (2015-2025)
10.5 Disturbed Sleep Revenue Growth Rate (2015-2025)
11 Global Sleep Disorder Therapies Market Segment by Application
11.1 Global Sleep Disorder Therapies Revenue Market Share by Application (2015-2020)
11.2 Sleep Disorder Therapies Market Forecast by Application (2019-2024)
11.3 Hospital Pharmacies Revenue Growth (2015-2020)
11.4 Online Pharmacies Revenue Growth (2015-2020)
11.5 Retail Pharmacies Revenue Growth (2015-2020)
12 Global Sleep Disorder Therapies Market Size Forecast (2021-2025)
12.1 Global Sleep Disorder Therapies Market Size Forecast (2021-2025)
12.2 Global Sleep Disorder Therapies Market Forecast by Regions (2021-2025)
12.3 North America Sleep Disorder Therapies Revenue Market Forecast (2021-2025)
12.4 Europe Sleep Disorder Therapies Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Sleep Disorder Therapies Revenue Market Forecast (2021-2025)
12.6 South America Sleep Disorder Therapies Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Sleep Disorder Therapies Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables
Table 1. Global Sleep Disorder Therapies Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Sleep Disorder Therapies by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Sleep Disorder Therapies Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Sleep Disorder Therapies Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Sanofi Corporate Information, Location and Competitors
Table 6. Sanofi Sleep Disorder Therapies Major Business
Table 7. Sanofi Sleep Disorder Therapies Total Revenue (USD Million) (2017-2018)
Table 8. Sanofi SWOT Analysis
Table 9. Sanofi Sleep Disorder Therapies Product and Solutions
Table 10. Sanofi Sleep Disorder Therapies Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Vanda Pharmaceuticals Corporate Information, Location and Competitors
Table 12. Vanda Pharmaceuticals Sleep Disorder Therapies Major Business
Table 13. Vanda Pharmaceuticals Sleep Disorder Therapies Total Revenue (USD Million) (2018-2019)
Table 14. Vanda Pharmaceuticals SWOT Analysis
Table 15. Vanda Pharmaceuticals Sleep Disorder Therapies Product and Solutions
Table 16. Vanda Pharmaceuticals Sleep Disorder Therapies Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Fisher and Paykel Healthcare Corporate Information, Location and Competitors
Table 18. Fisher and Paykel Healthcare Sleep Disorder Therapies Major Business
Table 19. Fisher and Paykel Healthcare Sleep Disorder Therapies Total Revenue (USD Million) (2017-2018)
Table 20. Fisher and Paykel Healthcare SWOT Analysis
Table 21. Fisher and Paykel Healthcare Sleep Disorder Therapies Product and Solutions
Table 22. Fisher and Paykel Healthcare Sleep Disorder Therapies Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Phillips Healthcare Corporate Information, Location and Competitors
Table 24. Phillips Healthcare Sleep Disorder Therapies Major Business
Table 25. Phillips Healthcare Sleep Disorder Therapies Total Revenue (USD Million) (2017-2018)
Table 26. Phillips Healthcare SWOT Analysis
Table 27. Phillips Healthcare Sleep Disorder Therapies Product and Solutions
Table 28. Phillips Healthcare Sleep Disorder Therapies Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Sleep Number Corporate Information, Location and Competitors
Table 30. Sleep Number Sleep Disorder Therapies Major Business
Table 31. Sleep Number Sleep Disorder Therapies Total Revenue (USD Million) (2017-2018)
Table 32. Sleep Number SWOT Analysis
Table 33. Sleep Number Sleep Disorder Therapies Product and Solutions
Table 34. Sleep Number Sleep Disorder Therapies Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Nox Medical Corporate Information, Location and Competitors
Table 36. Nox Medical Sleep Disorder Therapies Major Business
Table 37. Nox Medical Sleep Disorder Therapies Total Revenue (USD Million) (2017-2018)
Table 38. Nox Medical SWOT Analysis
Table 39. Nox Medical Sleep Disorder Therapies Product and Solutions
Table 40. Nox Medical Sleep Disorder Therapies Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Neurim Pharmaceuticals Corporate Information, Location and Competitors
Table 42. Neurim Pharmaceuticals Sleep Disorder Therapies Major Business
Table 43. Neurim Pharmaceuticals Sleep Disorder Therapies Total Revenue (USD Million) (2017-2018)
Table 44. Neurim Pharmaceuticals SWOT Analysis
Table 45. Neurim Pharmaceuticals Sleep Disorder Therapies Product and Solutions
Table 46. Neurim Pharmaceuticals Sleep Disorder Therapies Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Eight Sleep Corporate Information, Location and Competitors
Table 48. Eight Sleep Sleep Disorder Therapies Major Business
Table 49. Eight Sleep Sleep Disorder Therapies Total Revenue (USD Million) (2017-2018)
Table 50. Eight Sleep SWOT Analysis
Table 51. Eight Sleep Sleep Disorder Therapies Product and Solutions
Table 52. Eight Sleep Sleep Disorder Therapies Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Responsive Surface Technology Corporate Information, Location and Competitors
Table 54. Responsive Surface Technology Sleep Disorder Therapies Major Business
Table 55. Responsive Surface Technology Sleep Disorder Therapies Total Revenue (USD Million) (2017-2018)
Table 56. Responsive Surface Technology SWOT Analysis
Table 57. Responsive Surface Technology Sleep Disorder Therapies Product and Solutions
Table 58. Responsive Surface Technology Sleep Disorder Therapies Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Eli Lilly Corporate Information, Location and Competitors
Table 60. Eli Lilly Sleep Disorder Therapies Major Business
Table 61. Eli Lilly Sleep Disorder Therapies Total Revenue (USD Million) (2017-2018)
Table 62. Eli Lilly SWOT Analysis
Table 63. Eli Lilly Sleep Disorder Therapies Product and Solutions
Table 64. Eli Lilly Sleep Disorder Therapies Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Merck Corporate Information, Location and Competitors
Table 66. Merck Sleep Disorder Therapies Major Business
Table 67. Merck Sleep Disorder Therapies Total Revenue (USD Million) (2017-2018)
Table 68. Merck SWOT Analysis
Table 69. Merck Sleep Disorder Therapies Product and Solutions
Table 70. Merck Sleep Disorder Therapies Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Global Sleep Disorder Therapies Revenue (Million USD) by Players (2015-2020)
Table 72. Global Sleep Disorder Therapies Revenue Share by Players (2015-2020)
Table 73. Global Sleep Disorder Therapies Revenue (Million USD) by Regions (2015-2020)
Table 74. Global Sleep Disorder Therapies Revenue Market Share by Regions (2015-2020)
Table 75. North America Sleep Disorder Therapies Revenue by Countries (2015-2020)
Table 76. North America Sleep Disorder Therapies Revenue Market Share by Countries (2015-2020)
Table 77. Europe Sleep Disorder Therapies Revenue (Million USD) by Countries (2015-2020)
Table 78. Asia-Pacific Sleep Disorder Therapies Revenue (Million USD) by Countries (2015-2020)
Table 79. South America Sleep Disorder Therapies Revenue by Countries (2015-2020)
Table 80. South America Sleep Disorder Therapies Revenue Market Share by Countries (2015-2020)
Table 81. Middle East and Africa Sleep Disorder Therapies Revenue (Million USD) by Countries (2015-2020)
Table 82. Middle East and Africa Sleep Disorder Therapies Revenue Market Share by Countries (2015-2020)
Table 83. Global Sleep Disorder Therapies Revenue (Million USD) by Type (2015-2020)
Table 84. Global Sleep Disorder Therapies Revenue Share by Type (2015-2020)
Table 85. Global Sleep Disorder Therapies Revenue Forecast by Type (2021-2025)
Table 86. Global Sleep Disorder Therapies Revenue by Application (2015-2020)
Table 87. Global Sleep Disorder Therapies Revenue Share by Application (2015-2020)
Table 88. Global Sleep Disorder Therapies Revenue Forecast by Application (2021-2025)
Table 89. Global Sleep Disorder Therapies Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Sleep Disorder Therapies Picture
Figure 2. Global Sleep Disorder Therapies Revenue Market Share by Type in 2019
Figure 3. Insomnia Picture
Figure 4. Excessive Sleep Picture
Figure 5. Disturbed Sleep Picture
Figure 6. Sleep Disorder Therapies Revenue Market Share by Application in 2019
Figure 7. Hospital Pharmacies Picture
Figure 8. Online Pharmacies Picture
Figure 9. Retail Pharmacies Picture
Figure 10. Global Sleep Disorder Therapies Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Sleep Disorder Therapies Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Sleep Disorder Therapies Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Sleep Disorder Therapies Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Sleep Disorder Therapies Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Sleep Disorder Therapies Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Sleep Disorder Therapies Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Sleep Disorder Therapies Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Sleep Disorder Therapies Revenue Market Share in 2019
Figure 19. Global Top 10 Players Sleep Disorder Therapies Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Sleep Disorder Therapies Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Sleep Disorder Therapies Revenue Market Share by Regions (2015-2020)
Figure 23. Global Sleep Disorder Therapies Revenue Market Share by Regions in 2018
Figure 24. North America Sleep Disorder Therapies Revenue and Growth Rate (2015-2020)
Figure 25. Europe Sleep Disorder Therapies Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Sleep Disorder Therapies Revenue and Growth Rate (2015-2020)
Figure 27. South America Sleep Disorder Therapies Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Sleep Disorder Therapies Revenue and Growth Rate (2015-2020)
Figure 29. North America Sleep Disorder Therapies Revenue Market Share by Countries (2015-2020)
Figure 30. North America Sleep Disorder Therapies Revenue Market Share by Countries in 2019
Figure 31. USA Sleep Disorder Therapies Revenue and Growth Rate (2015-2020)
Figure 32. Canada Sleep Disorder Therapies Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Sleep Disorder Therapies Revenue and Growth Rate (2015-2020)
Figure 34. Europe Sleep Disorder Therapies Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Sleep Disorder Therapies Revenue Market Share by Countries in 2019
Figure 36. Germany Sleep Disorder Therapies Revenue and Growth Rate (2015-2020)
Figure 37. UK Sleep Disorder Therapies Revenue and Growth Rate (2015-2020)
Figure 38. France Sleep Disorder Therapies Revenue and Growth Rate (2015-2020)
Figure 39. Russia Sleep Disorder Therapies Revenue and Growth Rate (2015-2020)
Figure 40. Italy Sleep Disorder Therapies Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Sleep Disorder Therapies Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Sleep Disorder Therapies Revenue Market Share by Countries in 2019
Figure 43. China Sleep Disorder Therapies Revenue and Growth Rate (2015-2020)
Figure 44. Japan Sleep Disorder Therapies Revenue and Growth Rate (2015-2020)
Figure 45. Korea Sleep Disorder Therapies Revenue and Growth Rate (2015-2020)
Figure 46. India Sleep Disorder Therapies Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Sleep Disorder Therapies Revenue and Growth Rate (2015-2020)
Figure 48. South America Sleep Disorder Therapies Revenue Market Share by Countries (2015-2020)
Figure 49. South America Sleep Disorder Therapies Revenue Market Share by Countries in 2019
Figure 50. Brazil Sleep Disorder Therapies Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Sleep Disorder Therapies Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Sleep Disorder Therapies Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Sleep Disorder Therapies Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Sleep Disorder Therapies Revenue and Growth Rate (2015-2020)
Figure 55. UAE Sleep Disorder Therapies Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Sleep Disorder Therapies Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Sleep Disorder Therapies Revenue and Growth Rate (2015-2020)
Figure 58. Global Sleep Disorder Therapies Revenue Share by Type (2015-2020)
Figure 59. Global Sleep Disorder Therapies Revenue Share by Type in 2019
Figure 60. Global Sleep Disorder Therapies Market Share Forecast by Type (2021-2025)
Figure 61. Global Insomnia Revenue Growth Rate (2015-2020)
Figure 62. Global Excessive Sleep Revenue Growth Rate (2015-2020)
Figure 63. Global Disturbed Sleep Revenue Growth Rate (2015-2020)
Figure 64. Global Sleep Disorder Therapies Revenue Share by Application (2015-2020)
Figure 65. Global Sleep Disorder Therapies Revenue Share by Application in 2019
Figure 66. Global Sleep Disorder Therapies Market Share Forecast by Application (2021-2025)
Figure 67. Global Hospital Pharmacies Revenue Growth Rate (2015-2020)
Figure 68. Global Online Pharmacies Revenue Growth Rate (2015-2020)
Figure 69. Global Retail Pharmacies Revenue Growth Rate (2015-2020)
Figure 70. Global Sleep Disorder Therapies Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Sleep Disorder Therapies Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Sleep Disorder Therapies Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Sleep Disorder Therapies Revenue Market Forecast (2021-2025)
Figure 74. Europe Sleep Disorder Therapies Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Sleep Disorder Therapies Revenue Market Forecast (2021-2025)
Figure 76. South America Sleep Disorder Therapies Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Sleep Disorder Therapies Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel